Skandinaviska Enskilda Banken (SEB)’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-23,970
| Closed | -$16.2M | – | 424 |
|
|
2025
Q4 | $16.2M | Buy |
23,970
+2,021
| +9% | +$1.38M | 0.07% | 209 |
|
|
2025
Q3 | $14M | Sell |
21,949
-1,386
| -6% | -$841K | 0.06% | 228 |
|
|
2025
Q2 | $12.5M | Buy |
23,335
+6,978
| +43% | +$3.34M | 0.05% | 253 |
|
|
2025
Q1 | $6.87M | Sell |
16,357
-2,556
| -14% | -$1.11M | 0.03% | 348 |
|
|
2024
Q4 | $7.81M | Buy |
18,913
+1,900
| +11% | +$833K | 0.04% | 337 |
|
|
2024
Q3 | $8.6M | Hold |
17,013
| – | – | 0.04% | 293 |
|
|
2024
Q2 | $8.29M | Buy |
17,013
+1
| +0% | +$502 | 0.04% | 292 |
|
|
2024
Q1 | $9.19M | Sell |
17,012
-133
| -0.8% | -$72.7K | 0.04% | 289 |
|
|
2023
Q4 | $9.52M | Buy |
17,145
+520
| +3% | +$244K | 0.06% | 268 |
|
|
2023
Q3 | $7.27M | Buy |
16,625
+203
| +1% | +$101K | 0.05% | 304 |
|
|
2023
Q2 | $8.25M | Buy |
16,422
+1,749
| +12% | +$838K | 0.05% | 293 |
|
|
2023
Q1 | $7.34M | Sell |
14,673
-371
| -2% | -$178K | 0.05% | 313 |
|
|
2022
Q4 | $6.14M | Sell |
15,044
-114
| -0.8% | -$44.3K | 0.05% | 324 |
|
|
2022
Q3 | $4.94M | Sell |
15,158
-14,441
| -49% | -$5.3M | 0.04% | 365 |
|
|
2022
Q2 | $10.4M | Sell |
29,599
-992
| -3% | -$405K | 0.08% | 238 |
|
|
2022
Q1 | $16.7M | Sell |
30,591
-51,244
| -63% | -$27M | 0.1% | 197 |
|
|
2021
Q4 | $54.1M | Sell |
81,835
-31,237
| -28% | -$19.6M | 0.28% | 74 |
|
|
2021
Q3 | $70.3M | Sell |
113,072
-3,499
| -3% | -$2.35M | 0.39% | 59 |
|
|
2021
Q2 | $73.6M | Buy |
116,571
+9,857
| +9% | +$5.44M | 0.45% | 43 |
|
|
2021
Q1 | $52.2M | Sell |
106,714
-48,000
| -31% | -$24M | 0.34% | 63 |
|
|
2020
Q4 | $77.3M | Buy |
154,714
+13,621
| +10% | +$6.09M | 0.53% | 35 |
|
|
2020
Q3 | $55.5M | Buy |
141,093
+61,661
| +78% | +$22.8M | 0.41% | 57 |
|
|
2020
Q2 | $26.2M | Buy |
79,432
+8,654
| +12% | +$2.51M | 0.21% | 92 |
|
|
2020
Q1 | $17.1M | Buy |
70,778
+52,661
| +291% | +$13.7M | 0.17% | 120 |
|
|
2019
Q4 | $4.73M | Sell |
18,117
-152,831
| -89% | -$40.3M | 0.04% | 353 |
|
|
2019
Q3 | $46.5M | Buy |
170,948
+64,175
| +60% | +$17.9M | 0.39% | 60 |
|
|
2019
Q2 | $29.4M | Buy |
106,773
+92,348
| +640% | +$22.8M | 0.25% | 89 |
|
|
2019
Q1 | $3.23M | Sell |
14,425
-607
| -4% | -$125K | 0.03% | 363 |
|
|
2018
Q4 | $2.8M | Buy |
15,032
+1,851
| +14% | +$379K | 0.03% | 377 |
|
|
2018
Q3 | $3.29M | Sell |
13,181
-1,330
| -9% | -$323K | 0.03% | 376 |
|
|
2018
Q2 | $3.16M | Sell |
14,511
-52,723
| -78% | -$10.9M | 0.03% | 343 |
|
|
2018
Q1 | $12.9M | Sell |
67,234
-1,995
| -3% | -$368K | 0.12% | 127 |
|
|
2017
Q4 | $10.8M | Sell |
69,229
-36,018
| -34% | -$5.67M | 0.09% | 175 |
|
|
2017
Q3 | $16.4M | Sell |
105,247
-36,100
| -26% | -$5.71M | 0.15% | 124 |
|
|
2017
Q2 | $22.8M | Sell |
141,347
-600
| -0.4% | -$97.4K | 0.22% | 107 |
|
|
2017
Q1 | $21.9M | Hold |
141,947
| – | – | 0.22% | 94 |
|
|
2016
Q4 | $16.6M | Buy |
141,947
+123,247
| +659% | +$14.1M | 0.2% | 89 |
|
|
2016
Q3 | $2.11M | Buy |
18,700
+14,800
| +379% | +$1.56M | 0.02% | 460 |
|
|
2016
Q2 | $362K | Buy |
+3,900
| New | +$335K | ﹤0.01% | 650 |
|
Other funds holding IDXX
Skandinaviska Enskilda Banken (SEB)'s IDXX Position: Q1 2026 in Review
Skandinaviska Enskilda Banken (SEB) sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 23,970 shares — an estimated $16.2M sold.
Skandinaviska Enskilda Banken (SEB) first reported a position in IDXX in Q2 2016 and held it in 39 quarters. The position peaked at $77.3M in Q4 2020. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Skandinaviska Enskilda Banken (SEB) reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
- Skandinaviska Enskilda Banken (SEB) sold 23,970 Idexx Laboratories shares in Q1 2026, an estimated $16.2M.
- Skandinaviska Enskilda Banken (SEB) first reported a position in Idexx Laboratories in Q2 2016 and held it in 39 quarters.
- Skandinaviska Enskilda Banken (SEB)'s Idexx Laboratories position peaked at $77.3M in Q4 2020.
- 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.